Topic

Sylvant (siltuximab)

A collection of 13 issues

Lowering Out-of-Pocket for Sylvant (Siltuximab) with Blue Cross Blue Shield in Michigan: Copay Cards, Appeals & Financial Assistance

Answer Box: Getting Sylvant (Siltuximab) Covered by Blue Cross Blue Shield in Michigan Blue Cross Blue Shield of Michigan (BCBSM) requires prior authorization for Sylvant and covers it under the medical benefit only. The fastest path to approval: (1) Ensure your doctor documents HIV-negative and HHV-8-negative status with idiopathic multicentric

How Long Does It Take to Get Sylvant (siltuximab) Approved by Humana in Ohio? Complete Timeline & Approval Guide

Answer Box: Getting Sylvant (siltuximab) Approved by Humana in Ohio Timeline: 7-14 days for standard prior authorization; 72 hours if expedited due to medical urgency. Key requirement: Document HIV-negative and HHV-8-negative status with iMCD diagnosis meeting international consensus criteria. First step today: Have your oncologist/hematologist gather pathology reports, negative

How to Get Sylvant (Siltuximab) Covered by Cigna in Georgia: Prior Authorization, Appeals, and State Review Process

Answer Box: Getting Sylvant (Siltuximab) Covered by Cigna in Georgia Cigna requires prior authorization for Sylvant (siltuximab) with strict documentation including HIV-negative and HHV-8-negative test results plus pathology confirming idiopathic multicentric Castleman disease. HMO members need specialist referrals first; PPO/EPO members can go directly to oncology/hematology. If denied,

How to Get Sylvant (Siltuximab) Covered by Blue Cross Blue Shield in Ohio: Coding, Appeals, and State Review Process

Answer Box: Getting Sylvant Covered in Ohio Blue Cross Blue Shield Ohio requires prior authorization for Sylvant (siltuximab) as of May 2024. The fastest path to approval involves three key steps: 1) Submit proper coding (ICD-10 D47.Z2 for Castleman disease, HCPCS J2860 for billing), 2) Document HIV-negative and HHV-8-negative

How to Get Sylvant (Siltuximab) Covered by Humana in Virginia: Coding, Appeals, and State Review Process

Answer Box: Getting Sylvant Covered by Humana in Virginia Sylvant (siltuximab) requires prior authorization from Humana for idiopathic multicentric Castleman disease (iMCD). Use ICD-10 code D47.Z2 and HCPCS J-code J2860 (10 mg units). Submit PA requests through Humana's provider portal with HIV/HHV-8 negative test results and

How to Get Sylvant (Siltuximab) Covered by Humana in California: Complete Prior Authorization Guide

Answer Box: Getting Sylvant (Siltuximab) Covered by Humana in California Sylvant (siltuximab) requires prior authorization from Humana for patients with HIV-negative and HHV-8-negative multicentric Castleman disease. The fastest path to approval: (1) Confirm your diagnosis meets FDA criteria with recent negative HIV/HHV-8 lab results, (2) Have your oncologist complete

Get Sylvant (Siltuximab) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide 2025

Answer Box: Fast Track to Sylvant Coverage Yes, Blue Cross Blue Shield covers Sylvant (siltuximab) in New Jersey for FDA-approved idiopathic multicentric Castleman disease (iMCD), but prior authorization is required. Your fastest path: (1) Ensure you have documented HIV-negative and HHV-8-negative test results, (2) Have your physician submit the PA

Work With Your Doctor to Get Sylvant (Siltuximab) Approved by Humana in Illinois: Complete Provider Collaboration Guide

Answer Box: Getting Sylvant (Siltuximab) Covered by Humana in Illinois To get Sylvant (siltuximab) approved by Humana in Illinois, you need: confirmed multicentric Castleman disease diagnosis, HIV-negative and HHV-8-negative lab results, and oncologist consultation. Fastest path: Schedule a visit with your hematologist/oncologist to review your pathology reports and viral

Do You Qualify for Sylvant (Siltuximab) Coverage by UnitedHealthcare in Pennsylvania? Complete Decision Tree & Appeals Guide

Answer Box: Getting Sylvant Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Sylvant (siltuximab) but typically doesn't require step therapy for idiopathic multicentric Castleman disease (iMCD). You qualify if you're 18+, HIV-negative, HHV-8-negative, with confirmed iMCD via lymph node biopsy. Submit through the UnitedHealthcare

How to Get Sylvant (Siltuximab) Covered by Cigna in Illinois: Complete Decision Tree & Appeals Guide

Answer Box: Your Fastest Path to Sylvant Coverage Sylvant (siltuximab) requires prior authorization from Cigna for multicentric Castleman disease. You're eligible if you have confirmed idiopathic multicentric Castleman disease (iMCD) with documented HIV-negative and HHV-8-negative status. First step today: Have your doctor complete Cigna's Sylvant prior